Core Insights - DexCom (DXCM) is expected to report quarterly earnings of $0.57 per share, reflecting a 26.7% increase year-over-year, with revenues projected at $1.18 billion, an 18.4% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 0.8% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenue- Hardware' to be $39.65 million, showing a year-over-year decline of 6.5% [4]. - 'Revenue- Sensor and other' is projected at $1.14 billion, indicating a 19.6% increase from the year-ago quarter [5]. - 'Revenue- United States' is expected to reach $843.25 million, reflecting a 20.1% year-over-year increase [5]. - 'Revenue- International' is forecasted at $332.15 million, suggesting a 13.6% increase compared to the previous year [5]. Stock Performance - Over the past month, DexCom shares have returned 2.9%, while the Zacks S&P 500 composite has increased by 3.8% [6]. - Currently, DexCom holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [6].
Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics